发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING A SGLT2 INHIBITOR IN COMBINATION WITH A DPP-IV INHIBITOR |
摘要 |
The invention relates to a pharmaceutical composition according to claim 1 comprising a SGLT2 inhibitor in combination with a DPP IV inhibitor which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
|
申请公布号 |
US2011098240(A1) |
申请公布日期 |
2011.04.28 |
申请号 |
US20080673319 |
申请日期 |
2008.08.15 |
申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
发明人 |
DUGI KLAUS;MARK MICHAEL;HIMMELSBACH FRANK |
分类号 |
A61K31/7042;A61K31/5025;A61K31/519;A61K31/52;A61K31/7048;A61K31/7056;A61P3/04 |
主分类号 |
A61K31/7042 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|